Huons Lab registers patents and files PCT application for 11 antibody formulations

Verifying
  • Huons Lab registered domestic patents and filed a PCT application for 11 HyDIFFUZE-based antibody formulations.
  • PK testing showed Cmax of 113%-170% and AUC of 117%-162% versus formulations without HyDIFFUZE.
  • Huons Lab recently patented an ADC SC formulation and is targeting product approval this year.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.